The National Institutes of Health and the Foundation for the NIH (FNIH) are bringing together more than a dozen leading biopharmaceutical companies, the Health and Human Services Office of the Assistant Secretary for Preparedness and Response, the Centers for Disease Control and Prevention, the U.S… Learn more
POSTED: 5/4/2020
SOURCE: NIH Press Release
Updated: July 9, 2020
NCI participated in the American Association for Cancer Research (AACR) Annual Meetings, held virtually on April 27 - 28, 2020 (Meeting I) and June 22 - 24, 2020 (Meeting II), including presenting the following research results from PREVENT and Early Phase Clinical Projects… Learn more
POSTED: 4/29/2020
SOURCE: DCP News
This issue reveals there is no association between vitamin D supplementation and colorectal adenomas or polyps risk, that SAHA and EGCG promote apoptosis in breast cancer, and how the metabolome changes in colorectal cancer… Learn more
POSTED: 4/23/2020
SOURCE: DCP News
More than a decade after vaccination, women who had received a single dose of human papillomavirus (HPV) vaccine continued to be protected against cervical infection with the two cancer-causing HPV types targeted by the vaccine, HPV16 and 18. The new findings are from an extended follow-up of the… Learn more
POSTED: 4/10/2020
SOURCE: NCI Cancer Currents Blog
Women undergoing radiation therapy for cervical or uterine cancer have a much higher incidence of serious side effects than previously realized, according to results from a new clinical trial. This information may help women and their clinicians more accurately weigh the potential benefits versus… Learn more
POSTED: 4/8/2020
SOURCE: NCI Cancer Currents Blog
The chemotherapy drug doxorubicin is used to treat many types of cancer, but some patients who receive the drug develop heart problems. Using new insights into how doxorubicin damages the heart, researchers have identified an experimental drug that may help protect the heart.
POSTED: 4/6/2020
SOURCE: NCI Cancer Currents Blog